Corporate finance boutique Gambit has orchestrated four business deals in the last two weeks with a combined value in excess of £60m.
Transactions for the Cardiff-based firm including:
- Securing funding for The Rider Firm, a West-Sussex headquartered cycling e-retailer, from Santander to facilitate growth plans.
- Overseeing multi-million pound commercial mortgage for Creo Medical Group Plc, a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, from Barclays for its Chepstow HQ.
- The multi-million pound sale of the Communications Compliance Practise business of US headquartered TDS Global Holdings, an expert in legacy data management, to Kerv, an LDC portfolio company. The acquisition will strengthen Kerv’s existing portfolio and capabilities concerning all aspects of compliance and augment Kerv’s turnover to over £60m.
- A multi-million pound sale of Cwmtillery Glass Centre, one of the UK’s largest independent manufacturers of insulated glass units and toughened glass.
Since being established in 1992, the oldest independent corporate finance boutique in the UK, has transacted on deals with a cumulative value in excess of £3bn.
Geraint Rowe, partner, said: “We are delighted with delivering these transactions for our valued clients. The sales of TDS’ Communication Compliance Practice and Cwmtillery Glass Centre show that high quality assets continue to attract significant interest across different sectors. Vendors are taking advantage of realising value in what has been a resilient UK M&A market supported by widespread availability of low-cost capital, growth hungry private equity funds and an ever-increasing desire to execute transactions whilst favourable market conditions and tax climate present themselves.”
Fellow partner Jason Evans said: “Recent rate hikes are unsurprising, with high and persistent inflation driving the Bank of England towards constricting monetary policy, including larger and faster policy rate increases and accelerated quantitative tightening policies. However, despite macro-economic conditions, demand for capital market transactions has remained for high-quality borrowers the impact on debt sustainability remains limited in the near to medium-term. Funding is available for expansion with Barclays supporting Creo Medical with expanding its HQ in Chepstow and The Rider Firm securing funding to support its growth plans.”
Frank Holmes, a founding partner of Gambit, said: “After delivering a hugely successful 30 years, the past fortnight has shown that we have not slowed down and are still focussed on delivering client-orientated results. This comes on the back of a record year for Gambit in 2021 and expectation that 2022 will surpass that, underpinned by favourable sectoral tailwinds, our valued and exciting clients, a strong pipeline and a growing team.”
Read Next: Gambit celebrates 30 years in business
Read Next :Gambit acts of Cwmtillery Glass Centre
